
Sino Biological/Anti-KRAS Antibody, Rabbit Polyclonal/1/101667-T32
商品编号:
101667-T32
品牌:
sinobiological
市场价:
¥0.00
美元价:
0.00
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
Anti-KRAS Antibody, Rabbit Polyclonal General Information
Product name
Anti-KRAS Antibody, Rabbit Polyclonal
Validated applications
WB
Species reactivity
Reacts with: Human Predicted to React with: Mouse, Rat (Species predicted to react based on 100% sequence homology)
Specificity
Human KRAS
Immunogen
A synthetic peptide corresponding to the center region of the Human K-Ras
Preparation
Produced in rabbits immunized with a synthetic peptide corresponding to the center region of the Human K-Ras, and purified by antigen affinity chromatography.
Source
Polyclonal Rabbit IgG
Purification
Protein A & Antigen Affinity
Formulation
0.2 μm filtered solution in PBS
Conjugate
Unconjugated
Form
Liquid
Shipping
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
Anti-KRAS Antibody, Rabbit Polyclonal Validated Applications
Application | Dilution |
---|---|
WB | 1:500-1:1000 |
Please Note: Optimal concentrations/dilutions should be determined by the end user.
Anti-KRAS Antibody, Rabbit Polyclonal Images
-HD09JL3113-WB.png)
Anti-KRAS rabbit polyclonal antibody at 1:500 dilution.
Lane A: Mouse lung tissue lysate
Lysates/proteins at 30 μg per lane.
Secondary
Goat Anti- Rabbit IgG H&L (Dylight 800) at 1/10000 dilution.
Developed using the Odyssey technique.
Performed under reducing conditions.
Predicted band size:22 kDa
Observed band size:22 kDa
(We are unsure as to the identity of these extra bands.)
Anti-KRAS Antibody, Rabbit Polyclonal: Synonyms
Anti-C-K-RAS Antibody; Anti-CFC2 Antibody; Anti-K-RAS Antibody; Anti-K-RAS2A Antibody; Anti-K-RAS2B Antibody; Anti-K-RAS4A Antibody; Anti-K-RAS4B Antibody; Anti-KI-RAS Antibody; Anti-KRAS1 Antibody; Anti-KRAS2 Antibody; Anti-NS Antibody; Anti-NS3 Antibody; Anti-RALD Antibody; Anti-RASK2 Antibody
KRAS Background Information
K-Ras belongs to the small GTPase superfamily, Ras family. Like other members of the Ras family, K-Ras is a GTPase and is an early player in many signal transduction pathways. It is usually tethered to cell membranes because of the presence of an isoprenyl group on its C-terminus. K-Ras functions as a molecular on/off switch. Once it is turned on it recruits and activates proteins necessary for the propagation of growth factor and other receptors" signal, such as c-Raf and PI 3-kinase. It binds to GTP in the active state and possesses an intrinsic enzymatic activity that cleaves the terminal phosphate of the nucleotide converting it to GDP. Upon conversion of GTP to GDP, K-Ras is turned off. The rate of conversion is usually slow but can be sped up dramatically by an accessory protein of the GTPase activating protein class, for example, RasGAP. In turn, K-Ras can bind to proteins of the Guanine Nucleotide Exchange Factor class, for example, SOS1, which forces the release of bound nucleotide. Subsequently, K-Ras binds GTP present in the cytosol and the GEF is released from ras-GTP. Besides essential function in normal tissue signaling, the mutation of a K-Ras gene is an essential step in the development of many cancers. Several germline K-Ras mutations are associated with Noonan syndrome and Cardio-Facio-Cutaneous syndrome. Somatic K-Ras mutations are found at high rates in Leukemias, colon cancer, pancreatic cancer, and lung cancer.
- Cancer Immunotherapy
- Immune Checkpoint
- Immunotherapy
- Targeted Therapy
Full Name
Kirsten rat sarcoma viral oncogene homolog
Research Areas
- Cancer Drug Targets
References
- Ling J, et al. (2012) KrasG12D-induced IKK2//NF-B activation by IL-1 alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell. 21(1):105-20.
- Matallanas D, et al. (2011) Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras. Mol Cell. 44(6):893-906.
- Regala RP, et al. (2011) Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation. PLoS One. 6(10):e26439.
- EPHA2 feedback activation limits the response to PDEδ inhibition in KRAS-dependent cancer cellsAuthorChen, YH;Lv, H;Shen, N;Wang, XM;Tang, S;Xiong, B;Ding, J;Geng, MY;Huang, M;Year2019JournalActa Pharmacol. Sin.ApplicationWBPubMed ID: 31316177FoldedExpand
If you couldn"t find the specific citation, you can:
- Find All Citations
- Submit a CitationGet a Publication Reward
- Leave Us a Message
Recombinant Antibody Production Service
High-throughput Recombinant Antibody Production
Large-scale Antibody Production
Antibody Development Service
Rabbit MAb Production Service
Mouse MAb Production Service
Rabbit PAb Production Service
Phospho-Specific Antibody
Anti-Idiotype Antibody
Fast Antibody Development Service
Mouse MAb
Rabbit PAb
More Antibody Production Service
Hybridoma Antibody Production
Chimeric Antibody
Antibody Fragment
Bispecific Antibody
We also have Immunoassay Service. Click to see more.
品牌介绍
北京义翘神州科技股份有限公司(Sino Biological Inc.)是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司,主要业务包括重组蛋白、抗体、基因和培养基等产品,以及重组蛋白、抗体的开发和生物分析检测等服务。义翘神州为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。公司目前生产和销售的现货产品种类超过 4.6 万种,其中重组蛋白约 6,000 种,包括超过 3,800 种人源细胞表达重组蛋白产品,能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求;公司还能提供约 12,000 种抗体,其中单克隆抗体数量约 4,600 种,能够覆盖生命科学研究的多个领域,为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供「一站式」生物试剂产品和技术服务。义翘神州的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司,已成为生物试剂行业国内领先的科技公司之一。
联络我们